Procurement of these varieties or selection of proprietary Chinese medicines

With centralized procurement of proprietary Chinese medicines, three types of varieties may be selected.

01

Possible varieties of centralized procurement of Chinese patent medicines

Today, the author would like to discuss three issues with you, namely the centralized procurement of Chinese patent medicines, the creation of large-scale Chinese patent medicine products, and the marketing innovation of Chinese patent medicines

I remember that since the second batch of centralized procurement, news of the centralized procurement of proprietary Chinese medicines has been spread, but so far "this boot has not yet landed", in fact, today, all proprietary Chinese medicine companies are no longer paying attention to proprietary Chinese medicines.

From the point of view of the standards for centralized procurement of Chinese patent medicines, the author thinks that there are mainly the following three points:

1.

2.

3.

If an enterprise has such a proprietary Chinese medicine, it will be included in the centralized procurement category with a high probability

Similarly, for some other products, there is no need to worry about whether they will be included in centralized procurement, so which drugs will not be included in centralized procurement?

I think they are mainly the following categories: medicines containing authentic medicinal materials, exclusive varieties of traditional Chinese medicines, national protected varieties of traditional Chinese medicines, national secret prescriptions, national innovation awards, new listed varieties within 5 years, and post-market safety after passing more than 30,000 cases Sexually concentrated clinically validated drugs

Like these drugs, they are basically new products of Chinese medicine, or a category protected by the state

02

Path to build big products

When it comes to big, everyone will first think of the sales amount, but this is not the key, but the value that the drug brings to the treatment of diseases is the real key.

1.

2.

3.

4.

5.

In these five aspects, the top-level product design and academic creation will be the key to the success of large-scale product creation

For example, Yiling Pharmaceutical's Tongxinluo is a benchmark product for large-scale Chinese patent medicines
.
His success comes from a solid academic system and perfect marketing path
.

The academic path of proprietary Chinese medicine is nothing more than three aspects: the first is the theory of Chinese medicine, the second is the extensive human experience, and the third is the full verification of evidence-based medicine
.
On the other hand, Tongxinluo, based on the theory of collateral disease, has established collateral disease research centers in many hospitals and scientific research units across the country, and combined with the clinical indications of Tongxinluo, it has established doctors' confidence in medication with excellent curative effects
.
In addition, from the strategic development of products, extensive evidence-based medical research, and the establishment of large samples of clinical data, Tongxinluo has become the first choice for the treatment of related diseases
.

There are many factors for the success of large-scale product creation, and I will not repeat them one by one today, but the "three-in-one" system created by academics is the key to the success of Chinese patent medicines
.

03

Marketing Innovation of Chinese Patent Medicine

The reason why we talk about innovation is that the difficulties and challenges we are facing now cannot be solved with past experience and methods.
For example, hospital admission of Chinese patent medicine is an increasingly serious problem.
No matter how good the product is, if If access is not resolved, the sales of the product and its own value cannot be realized
.

Hospital admission is another topic that we cannot circumvent, because the country's medical reform policy determines the standards and quantity of medicines used in hospitals, that is, the standards are getting higher and higher, and the number is getting less and less
.

Therefore, in order to realize the value of the product, it is necessary to consider how to bypass the topic of hospital access
.
The innovative model I talked about today is the model of out-of-hospital marketing, that is, doing a good job in the academic publicity of doctors, and finally realizing product sales outside the hospital
.

The author recently came into contact with several of these proprietary Chinese medicines, which have good curative effects and clear indications, but they cannot be sold in hospitals due to policy reasons
.
Therefore, through the out-of-hospital model, the product marketing skills were reshaped, and the publicity and education of patients were strengthened, and finally achieved satisfactory results
.

When it comes to outside the hospital, you may immediately think of retail pharmacies and OTC products, and feel that our marketing routines are different, which reduces the academic content of our products
.
But thinking carefully, the out-of-hospital model also requires a good doctor’s work.
Our focus is still in the hospital.
This is no different from the previous in-hospital prescription drug sales.
The difference is the acceptance process of hospital doctors.
From the perspective of our current operation, it is the best choice to operate the out-of-hospital mode under the premise that Chinese patent medicine cannot solve the problem of entering the hospital
.

According to authoritative statistics, there are currently more than 1,500 companies in the proprietary Chinese medicine industry with a scale of more than 20 million.
This shows that the competition is fierce.
To stand out in such a market environment, what is needed is not just some big products, but more importantly, innovation.
Model thinking, and a love and sentiment for the cause of Chinese medicine
.

04

Heart-strengthening needle for Chinese medicine companies

After talking about the above three topics, take a look at the recent hot topics of Chinese medicine-there are not many hot news related to Chinese medicine in the first half of this year, but there are a few items worthy of everyone's attention
.

First, on May 12, the top leader of the country came to Nanyang, Henan for investigation and investigation.
First, he came to the Medical Sacred Shrine to learn about the life of Zhang Zhongjing, a medical scientist in the Eastern Han Dynasty, and his contribution to the development of Chinese medicine
.

Second, on May 24, Yu Yanhong, a member of the Party Leadership Group of the National Health Commission and Secretary of the Party Leadership Group of the State Administration of Traditional Chinese Medicine, went to Nanyang, Henan Province for investigation, focusing on the promotion of traditional Chinese medicine culture and the improvement of service capacity building
.

Thirdly, on July 20 this year, with the approval of the Central Editing Office, the Provincial Party Committee’s editorial board officially approved the Zhejiang Provincial Health Commission to add the Zhejiang Provincial Traditional Chinese Medicine Administration brand, and set up the Traditional Chinese Medicine Comprehensive Management Office and the Traditional Chinese Medicine Inheritance and Innovation Office
.

After the Zhejiang Provincial Administration of Traditional Chinese Medicine is listed, it means that the administrative functions of the current Zhejiang Provincial Administration of Traditional Chinese Medicine have been further strengthened
.
The former Zhejiang Provincial Administration of Traditional Chinese Medicine has also been upgraded from the departmental level to a department-level organization
.

Without interpreting too much, I think everyone can also feel the content and meaning behind these few news.
This is undoubtedly a booster for Chinese medicine companies, and makes everyone full of confidence and expectations for future development
.

Of course, for everyone, the first thing to do is to solve the current problems and better plan for the future
.

Traditional Chinese medicine is a treasure of our country, but it also requires continuous innovation and perseverance in the inheritance
.